We serve Chemical Name:2-Nitro-2-phenylpropane-1,3-diol CAS:5428-02-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Nitro-2-phenylpropane-1,3-diol
CAS.NO:5428-02-4
Synonyms:2-nitro-2-phenylpropane-1,3-diol
Molecular Formula:C9H11NO4
Molecular Weight:197.18800
HS Code:2906299090
Physical and Chemical Properties:
Melting point:100-102ºC
Boiling point:396ºC at 760 mmHg
Density:1.337g/cm3
Index of Refraction:1.58
PSA:86.28000
Exact Mass:197.06900
LogP:0.66640
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077
Packing Group:
Contact us for information like 2-nitro-2-phenylpropane-1,3-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-nitro-2-phenylpropane-1,3-diol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-nitro-2-phenylpropane-1,3-diol Use and application,2-nitro-2-phenylpropane-1,3-diol technical grade,usp/ep/jp grade.
Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 2-Nitro-2-phenylpropane-1,3-diol manufacturer “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. 2-Nitro-2-phenylpropane-1,3-diol supplier Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. 2-Nitro-2-phenylpropane-1,3-diol vendor Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. 2-Nitro-2-phenylpropane-1,3-diol factory Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).
